Harmony Biosciences Holdings (HRMY)
Pretax margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 191,804 | 175,338 | 165,000 | 187,401 | 173,396 | 177,810 | 133,945 | 119,081 | 104,686 | 85,058 | 66,569 | 53,427 | 37,428 | 12,747 | 25,178 |
| Revenue (ttm) | US$ in thousands | 710,199 | 672,548 | 630,000 | 585,184 | 548,499 | 507,747 | 476,532 | 451,378 | 419,060 | 383,158 | 319,980 | 290,957 | 268,890 | 236,824 | 233,336 |
| Pretax margin | 27.01% | 26.07% | 26.19% | 32.02% | 31.61% | 35.02% | 28.11% | 26.38% | 24.98% | 22.20% | 20.80% | 18.36% | 13.92% | 5.38% | 10.79% |
December 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $191,804K ÷ $710,199K
= 27.01%
The pretax margin of Harmony Biosciences Holdings has shown fluctuations over the analyzed periods. It increased from 10.79% on June 30, 2021, to 35.02% on September 30, 2023, reflecting an upward trend in profitability. However, the margin decreased to 26.07% on September 30, 2024, and then slightly rebounded to 27.01% on December 31, 2024.
It is worth noting that the company experienced a significant improvement in pretax margin between June 30, 2022, and December 31, 2023, where the margin increased from 20.80% to 31.61%. This increase could indicate enhanced operational efficiency or effective cost management during this period.
Overall, the pretax margin of Harmony Biosciences Holdings has displayed volatility, with periods of strong growth followed by fluctuations. Monitoring future trends in the pretax margin will be crucial in assessing the company's financial performance and profitability going forward.
Peer comparison
Dec 31, 2024